Official SUTENT® site—Educational resources

Medication Guide | Site Map | Full Prescribing Information

Home

About GIST

SUTENT and GIST

Insurance help from First Resource

Tools for patients

Tools for caregivers

Education and support

Common SUTENT questions

Video Q and A

GIST Question Builder

Educational resources

SUTENT Patient Call Center

Support resources

Terms to know

Important safety information

Get e-mail updates

Treating RCC with SUTENT

E-mail this page to a friend

Printer-friendly page

Back

SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec^® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec. Gleevec is a registered trademark of Novartis AG.

The printable brochures below offer:

Useful cancer information
Facts about SUTENT^®
Reimbursement information

GIST materials

Understanding GIST, a cancer that affects the digestive system brochure
Get the Understanding GIST brochure now

Information about GIST and its causes, stages, and treatments
Facts about tests for GIST
Questions for your doctors or nurses
A list of terms to know
Cancer and patient support resources

First Resource^® materials

First Resource brochure
Get the First Resource brochure now

How to contact SUTENT reimbursement counselors at First Resource
Reimbursement and patient assistance information

First Resource enrollment form
Get the First Resource enrollment form now

NEXT: SUTENT Patient Call Center

In order to view PDF documents, you must have Adobe^® Reader^® installed on your computer. If you do not have Adobe Reader, download it from the Adobe Web site.

Note that the Adobe Web site is neither owned nor controlled by Pfizer. Pfizer is not responsible for the content or services on that site.

Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.

SUTENT is used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC).

SUTENT is used to treat GIST (gastrointestinal stromal tumor). This is a rare cancer of the stomach, bowel, or esophagus. SUTENT is used when the medicine Gleevec^® (imatinib mesylate) did not stop the cancer from growing or when you cannot take Gleevec.

Important Safety Information

SUTENT can cause serious liver problems, including death.

Tell your healthcare provider right away if you develop any of the following during treatment with SUTENT: itching; yellow eyes or skin; dark urine; or pain or discomfort in the right upper stomach area.

Your healthcare provider should do blood tests to check your liver function before you start taking SUTENT and during treatment.

SUTENT may cause heart problems. Heart problems may include heart failure, heart muscle problems (cardiomyopathy) or abnormal heart rhythm changes. Tell your healthcare provider if you feel dizzy, faint, very tired, have abnormal heartbeats, are short of breath, or have swollen feet and ankles while taking SUTENT.

SUTENT may cause high blood pressure. Your healthcare provider may check your blood pressure, and may treat you for high blood pressure.

SUTENT may cause bleeding sometimes leading to death. Tell your healthcare provider right away if you have any of following during treatment with SUTENT: serious bleeding; painful swollen stomach (abdomen); vomiting blood; black sticky stools; bloody urine; headache or change in your mental status.

SUTENT may cause hormone problems, including thyroid and adrenal gland problems. Your healthcare provider may do tests to check your thyroid and adrenal gland function during SUTENT treatment.

SUTENT may harm an unborn baby (cause birth defects). Do not become pregnant. If you do, tell your healthcare provider right away. Stop taking SUTENT. Do not breastfeed while taking SUTENT.

Using SUTENT with other medicines can cause serious side effects. Tell your healthcare provider about all the medicines, vitamins, or herbal products you use.

You may have side effects or reactions to SUTENT. For most patients, these are moderate and may be managed, though some can be serious. Your healthcare provider may change your dose or stop your treatment. Some of the most common side effects include tiredness, weakness, fever, diarrhea, nausea, vomiting, mouth sores, upset stomach, abdominal pain, constipation, skin or hair changes, taste changes, swelling, loss of appetite, and bleeding, such as from the nose or cuts. Tell your healthcare provider if you have any swelling or bleeding. Be sure to tell your healthcare provider about any new side effects you have, as well as any change or increase in any side effect.

Gleevec is a registered trademark of Novartis AG.

Please see patient Medication Guide and full prescribing information.

Pfizer is a licensee of the TRUSTe Privacy Program.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

This product information provided in this site is intended only for residents of the United States. The products discussed herein may have different labeling in different countries.